Skip Navigation



Carcinogenesis Advance Access published online on April 8, 2009

Carcinogenesis, doi:10.1093/carcin/bgp080
This Article
Right arrow Advance Access manuscript (PDF)
Right arrow All Versions of this Article:
30/6/937    most recent
bgp080v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Matteucci, E.
Right arrow Articles by Desiderio, M. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Matteucci, E.
Right arrow Articles by Desiderio, M. A.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2009. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

Nuclear Localization of Active Hgf-Receptor Met in Aggressive Mda-Mb231 Breast Carcinoma Cells

Emanuela Matteucci, Paola Bendinelli and Maria Alfonsina Desiderio*

Dipartimento di Morfologia Umana e Scienze Biomediche "Città Studi", Molecular Pathology Laboratory, University of Milan- 20133 Milan- Italy

* To whom correspondence should be addressed, Dipartimento di Morfologia Umana e Scienze Biomediche "Città Studi", Molecular Pathology Laboratory, School of Medicine, University of Milan, via Luigi Mangiagalli, 31- 20133 Milan, Italy. Tel: +39/0250315334; Fax: +39/0250315338; E-mail: a.desiderio{at}unimi.it

HGF/Met system is deregulated in tumors and is implicated in different aspects of invasive growth. Here we report that in the highly aggressive MDA-MB231 breast carcinoma cells, Met cytosolic fragments (CTF) were present in the nuclei. They were constitutively active because tyrosine phosphorylated at regulatory and catalytic domains, and endowed with transactivating activity independently of HGF exposure. In fact, various constructs containing Juxtamembrane (Jxtm)-Met fragments, fused with Gal4 DNA binding domain, transactivated Gal4Luc activity. MDA-MB231 cells were devoid of WW domain-containing oxidoreductase (Wwox) tumor suppressor. Exogenous Wwox protein expression negatively regulated Jxtm3 transactivating activity and decreased spontaneous migration of MDA-MB231 cells. Also, we demonstrate that the lack of endogenous Wwox in MDA-MB231 cells represented a molecular mechanism for intranuclear Met-CTF accumulation and for the decrease of full-length Met stability. Yes-associated proteins (YAPs) maintained constitutively activated nuclear Met fragments, that played a role as transcription factors regulating genes probably including those for motile phenotype. The difference with low invasive MCF-7 cells was evident, because the latter did not show intranuclear Met and the transfected constructs containing Jxtm fragments were inactive also in the presence of HGF. The constitutive activation of nuclear Met signaling pathway in MDA-MB231 cells, possibly determined at genetic or epigenetic levels of WWOX gene, might participate in breast carcinoma progression influencing invasive/metastatic phenotype. WWOX/Met system can be suggested as a potential target to impair breast carcinoma progression.

Received February 5, 2009; revised March 30, 2009; accepted March 31, 2009.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.